Redmond Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Redmond Asset Management's GILD Position: Q4 2017 in Review
Redmond Asset Management sold out of Gilead Sciences (GILD) in Q4 2017, closing a stake of 21,310 shares — an estimated $1.73M sold.
Redmond Asset Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $5.35M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.
- Redmond Asset Management reported no remaining Gilead Sciences position as of Q4 2017 after selling out during the quarter.
- Redmond Asset Management sold 21,310 Gilead Sciences shares in Q4 2017, an estimated $1.73M.
- Redmond Asset Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
- Redmond Asset Management's Gilead Sciences position peaked at $5.35M in Q2 2015.
- 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.
Based on Redmond Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.